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Background: Cross sectional study was carried out to detect
mycobacteria in raw milk samples of from Fulani heards in Bwari
Area council,Nigeria,ZN-stain technique,PCR and culture on LJ
slants. Heard prevelence,Knowlede attidue with associated risk
factors for transmission of zoonotic TB were evaluated using struc-
tured questionnires.
Methods & Materials: Study Area Bwari area council (BAC) is
one of the six area councils of the Federal capital territory. Located
along cordinates 7◦ 8′′ E and 9◦ 24′′ N. Study Population: The pas-
toral Fulanis of Abuja are transhumant. They rear cattle,sheeps
and Goats. Sampling: Milk samples were collected by cattle owner
into 50ml sterile falcon tubes as part of there routine milk collec-
tion,labled and transported to the laboratory in cold chain. Samples
were tested for M.bovis by PCR,ZN stain and cultured on LJ slants
(ﬁgure 2).
Results: One hundred and forty ﬁve samples were analyzed.
Positive detection rates by ZN-staining and culture were 6.89% and
1.3% by PCR respectively. Herd prevalence per satellite town by
ZN-stain technique were 8.89%, 10.00%, 3.33% and 5.00% for Bwari,
Dei-Dei, Kubuwa and Ushafa respectively, while by culture they
were 2.22%, 10.00%, 13.33% and 5.00% for Bwari, Dei-Dei, Kubuwa
and Ushafa respectively. Herd prevalence by PCR for Bwari was
2.22% while that of Dei-Dei was 3.33%. Kubuwa and Ushafa had 0%
prevalence each by PCR. Awareness level on cause and transmis-
sion mode of M.bovis from cattle to human through questionnaire
revealed 64% (11/17) and 82% (14/17) were neither aware of the
causative agent nor its zoonotic signiﬁcance respectively. There
was high risk of M,bovis transmission due to frequent raw milk
consumption without boiling (OR = 5.76; CI= 1.32 – 25.18 and OR=
0.0947; CI = 0.0194 - 0.4619) with P < 0.05 respectively in the
studied herds .
Conclusion: Mycobacterium bovis was detected in cow’s milk
from Fulani herds of Bwari Area council, calls for implementation
of public health control measures such as improved hygiene and
milk pasteurization.
http://dx.doi.org/10.1016/j.ijid.2016.02.554
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Background: Neuraminidase inhibitors (NAIs) were widely
deployed during the 2009 A(H1N1) pandemic. While evidence
exists to support their effectiveness in reducing mortality in hos-
pitalised patients, the impact of outpatient or community-based
treatment on hospital admission has not been established. Our
aim was to investigate the association between outpatient or
community-based NAI treatment and admission to hospital in
patients with A(H1N1)pdm09 virus infection.
Methods & Materials: We performed an Individual Participant
Data (IPD) meta-analysis on a pooled dataset of 6,030 patients
from nine different countries. ‘Admission to hospital’ was the main
outcome and ‘NAI treatment initiated in the community or as an
outpatient’ was the main exposure variable. We estimated Odds
Ratios (OR) and 95% Conﬁdence Intervals (95% CI) using gener-
alised linear mixed modelling to account for clustering within
each contributing study centre; and we adjusted for pre-admission
antibiotics and NAI treatment propensity in the ﬁnal model. To
account for relatively frequent exposure to NAI treatment and an
overall high likelihood of hospitalisation, we also estimated Risk
Ratios (RR) using a random effects probit model.
Results: Of the 6,030 patients included in the pooled
analysis, 5,738 (95.16%) had laboratory conﬁrmed inﬂuenza
A(H1N1)pdm09, and the remainder were clinically diagnosed
with ‘pandemic inﬂuenza’. A total of 1,541 patients (25.56%)
received outpatient or community-based NAI treatment and 4,250
(70.48%) hospitalisations occurred, indicating a population at over-
all high-risk of inﬂuenza-related hospitalisation. After adjustment
for pre-admission antibiotics and NAI treatment propensity, out-
patient or community-based NAI treatment was associated with
a decreased odds of hospital admission (OR: 0.33, 95% CI: 0.28 to
0.39) compared to no NAI treatment. From our random effects pro-
bit model, we obtained a corresponding adjusted RR of 0.52 (0.48
to 0.57).
Conclusion: In a population with conﬁrmed or suspected
A(H1N1)pdm09, and at high risk of hospital admission, outpatient
or community-based NAI treatment substantially reduced the like-
lihood of requiring hospital admission.
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